Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval Variation.

Oli, Avadhesh

Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval Variation. [electronic resource] - American journal of ophthalmology 03 2018 - 168-169 p. digital

Publication Type: Letter; Comment

1879-1891

10.1016/j.ajo.2017.12.009 doi


Angiogenesis Inhibitors
Antibodies, Monoclonal
Bevacizumab
Diabetic Retinopathy
Humans
Vascular Endothelial Growth Factor A
Vitrectomy
Vitreous Hemorrhage